Dr. Luca Boselli joined the Nanobiointeractions & Nanodiagnostics Laboratory at the Istituto Italiano di Tecnologia (IIT) in Genova in November 2019, where he currently holds the position of Researcher. His work focuses on nanomedicine, particularly nanozymes and plasmonic nanoparticles for therapeutic and diagnostic applications. In recent years, he has investigated the physicochemical processes underlying nanozyme activity, their interactions with biomolecules and cellular systems, and the mechanisms driving their antioxidant and anti-inflammatory effects. He also leads a research initiative on hybrid nanoparticle-bacteriophage nanoconstructs for biomedical applications.
Dr. Boselli earned an MSc in Photochemistry and Material Chemistry from the University of Bologna in 2011, followed by a PhD in Organometallic Chemistry from the University of Toulouse in 2014. His doctoral research at the Laboratory of Coordination Chemistry (LCC) of the French National Research Centre (CNRS) focused on developing bioactive organometallic compounds for cancer, malaria, and leishmaniasis treatment.
From 2015 to 2019, he was a postdoctoral fellow at the Center for Bionano Interactions, University College Dublin. His research involved synthesizing and characterizing various inorganic and biomimetic nanostructures, analyzing their interactions with biological environments. He focused on the "biomolecular corona" phenomenon and its impact on key biological processes such as targeting, toxicity, cellular uptake, biodistribution, and immune response.